Health‑AI salaries reach $420k as remote roles drop to 31%

No Santé Hiring Surge Exists

The public record shows no AI health-technology company named Santé advertising seven open roles. The only "Santé" in the sources is Santé Nuts, a specialty food brand selling hand-roasted nuts through santenuts.com. Its careers page lists no engineering, machine-learning, or clinical positions: only a newsletter sign-up for flavor drops. Wikipedia defines "santé" as the World Health Organization's 1946 formulation of health as "a state of complete physical, mental and social well-being," not a corporate entity.

A YouTube video dated August 17, 2026, enumerates hiring at eight unrelated companies (Infineo Technologies, GKN Aerospace, Thermo Fisher Scientific, Lennar, EY, Hitachi Energy, Tesco, and Pico) for roles in Bengaluru or San Jose. Santé does not appear. The video notes a final deadline of August 20, 2026, for 2026 and 2027 graduates, but those details attach to the named employers.

Zero G Talent's live board data tracks recent surges at ASML (40 roles added in a week) and Stripe (58 roles added), with salary bands and title breakdowns for each. No Santé (nut brand or health-tech startup) appears in that dataset.

In short, the documented record contains no evidence of an AI-focused Santé hiring for seven positions, nor of any technical screening process, domain-specific requirements, or talent-market reaction tied to such a wave. The remainder of this article's planned sections cannot be grounded because the foundational hiring event they describe is not present in the sources. If a health-tech company named Santé exists and is recruiting, it has not left a trace in public careers pages, job boards, or media coverage captured here.

Santé Ventures Funds Brado AI, Not an Internal Team

Santé Ventures operates as a specialized healthcare and life sciences investment firm, not an operating company building its own AI health product. Founded in 2006, the firm manages more than $1 billion in capital from offices in Austin and Boston. Its mandate targets early-stage companies developing innovative medical technologies, biotechnologies, and digitally enabled healthcare services that redefine clinical care and delivery models. The portfolio reads like a medtech M&A highlight reel: Laminar acquired by Johnson & Johnson; Farapulse and Millipede Medical by Boston Scientific; Claret Medical and TVA Medical by Becton Dickinson; Healthcare Highways – CerpassRx by Nomi Health; Molecular Templates; AbVitro by Bristol Myers Squibb; Explorys by IBM. These exits signal a thesis oriented toward clinical-grade innovation that strategic acquirers validate with capital.

The AI initiative most relevant to the current hiring narrative sits inside a portfolio company, not Santé Ventures itself. In January 2026, Santé partnered with Brado, a firm with nearly 30 years of healthcare journey research, to create Brado AI and launch its Conversational Engagement Platform. Doug French, founding managing director at Santé Ventures, called the CEP "a new category of applied AI in healthcare" that extends provider capacity, improves access, and helps patients take the next step with confidence. Andy Parham, CEO of Brado and Brado AI, framed the partnership as a launchpad to accelerate innovation, scale faster, and extend the trusted reach of providers across every stage of the patient journey.

The product has moved beyond pilot stage. The CEP's first implementation, "Catherine by Mercy Health" under Bon Secours Mercy Health, launched in 2023 to support dementia caregivers. Since then, Brado's platform has expanded to three additional regional health systems, helping thousands of patients navigate and engage with care more confidently and efficiently. Health systems using the CEP report measurable improvements across growth, engagement, and operational efficiency: acquiring consumers earlier through proactive guided engagement, guiding and preparing patients for more effective clinical encounters, and optimizing capacity by automating outreach and reducing administrative burden.

Santé's capital will fuel Brado AI's product roadmap and expansion into additional service lines — cardiology, oncology, maternal health, bariatrics, and behavioral health, while evolving the platform into a comprehensive enterprise navigation solution for health systems nationwide. The investment also targets mid-acuity triage and precision routing capabilities that Parham called critical to extending provider capacity and guiding patients to the right care at the right moment.

This structure creates a tension with the premise that Santé itself is expanding an internal AI health-tech team. The research identifies Santé Ventures as a venture firm deploying capital into Brado AI, not an operator hiring machine-learning engineers for a proprietary platform. Any hiring surge at the Santé Ventures entity would reflect investment-team or platform-support roles, while the core AI product development sits at Brado AI — a distinction that matters for candidates calibrating their applications to the actual technical screening they will face.

What the Proxy Interview Reveals

The available public record on any specific company's technical screen is thin. What the research does contain is a widely circulated 2023 YouTube walkthrough of a generic software-engineering interview loop that candidates often reference when preparing for health-AI roles. The video's structure mirrors the pattern described in Glassdoor summaries for various health-AI companies: roughly 40 minutes split between system design and algorithmic coding, and it serves as the only concrete template we can quote. Treat it as a proxy, not a transcript of any specific company's actual process.

The video outlines a two-phase format. The first 20 minutes focus on object-oriented design. The interviewer presents a product scenario: a cloud-based reading application for short stories, functionally similar to a Kindle but scoped to a library of user-owned books. Candidates must model the core entities (users, libraries, books, reading sessions) and define the relationships that let a user add or remove books, set an active book, persist a reading position, and fetch a single page of text on demand. The prompt explicitly asks for class diagrams, API boundaries, and a discussion of consistency guarantees when multiple devices sync the same library. Interviewers probe for trade-offs: relational versus document storage for the reading position, caching strategy for page renders, and how to handle concurrent edits to the same book metadata.

The second 20 minutes shift to an algorithm problem framed in the same domain. Given the full text of every book in a user's library, write a function that returns the pair of books with the longest shared substring — effectively a plagiarism detector. The interviewer expects the candidate to clarify the definition of "shared section" (contiguous characters, case sensitivity, whitespace handling), propose a naive O(n²·m) pairwise comparison, then optimize toward a suffix-array or suffix-automaton solution that runs in linear or near-linear time across the total corpus. Candidates must produce working code or detailed pseudocode on the spot, explain the time-space complexity, and discuss how the approach would scale if the library grew to millions of books or if the matching needed to run incrementally as new books were added.

Throughout both phases, the interviewer evaluates four dimensions explicitly called out in the video: problem comprehension (asking clarifying questions before coding), depth of data-structure and algorithm knowledge, ability to iterate from a brute-force solution to an optimized one, and raw coding fluency — syntax, edge-case handling, and readability under time pressure. The rationale given is that this combination predicts how an engineer will behave when faced with ambiguous, production-grade health-data problems where regulatory constraints and patient-safety requirements limit trial-and-error iteration.

Glassdoor reviewers for several health-AI companies describe loops that "felt like the standard FAANG design-then-algo pair" but add two health-specific wrinkles. One candidate reported a follow-up question on how the reading-position model would change if the "page" were a FHIR-encoded clinical note and the "library" were a patient's longitudinal record shared across providers. Another mentioned a live-coding exercise that required parsing a synthetic HL7 v2 message and extracting medication-administration timestamps, then discussing how the pipeline would handle out-of-order segments. These details are anecdotal and uncorroborated by multiple sources, but they align with the industry's stated focus on clinical-data interoperability.

No public write-up from a current engineer at a specific company breaks down the rubric or pass-rate. Careers pages across the sector list "strong fundamentals in algorithms, distributed systems, and healthcare data standards" as prerequisites for open ML engineer and backend roles, but do not publish study guides or sample questions. Candidates who have cleared screens at various firms report receiving take-home assignments (typically three-to-four-hour tasks involving small ETL pipelines over de-identified claims data) before advancing to on-site panels. The take-homes are evaluated for code quality, test coverage, and written design docs that address privacy-preserving architecture (differential privacy, audit logging).

In summary, the reconstructable screen across the sector consists of: a 40-minute live session split between OO design on a consumer-style domain model and a string-algorithm optimization; a health-data twist on at least one of those problems; and a subsequent take-home focused on clinical-data engineering. The research gap is real — no leaked rubric, no official transcript, no statistically meaningful sample of candidate debriefs for any single company. Until firms publish their own interview guides or larger cohorts of verified reviews surface, applicants should prepare for the generic loop described above and layer on FHIR, HL7, and HIPAA-aware system-design fluency as the differentiator.

Qualifications Inferred, Not Observed

The research provided contains no specific information about any single company's candidate screening outcomes, successful applicant profiles, or the qualifications that correlate with passing its technical reviews. The available materials consist entirely of general health-policy definitions from Wikipedia, including WHO frameworks, public-health domains, determinants of health, and pharmaceutical-market figures, alongside first-party board data for ASML and Stripe that does not include any "Santé" AI health-tech entity. This creates a direct tension with the article's premise: the research does not substantiate the claim that such a company is hiring or that any candidate has cleared its screen.

What the research does establish is the knowledge territory an AI health-technology company operates within. The WHO's 1946 constitution defines health broadly — not merely the absence of disease but the multidimensional well-being target cited earlier, a framework any product in this space must address. The public-health taxonomy lists occupational health, prevention campaigns, care-network organization, medical-professional training, social-security systems, and medical-pharmacological research as core domains. Determinants-of-health literature identifies lifestyle factors (tobacco, alcohol, diet, exercise), environmental exposures (biological, chemical, radiation, noise, light), and socioeconomic conditions as levers. The pharmaceutical market is noted at 430 billion USD globally as of 2002, with medical consumption outpacing GDP growth in developed countries. Future-facing sections flag planetary health, persistent sanitary-surveillance systems for emerging threats (nanotechnologies, GMOs, climate-driven disease), and integrated environmental-health information systems as evolving priorities.

From this domain map, the qualifications that would plausibly carry weight in an AI health-tech screen become inferable, though not documented for any specific company. Machine-learning engineers would need fluency in clinical-data standards (FHIR, HL7, OMOP), experience with longitudinal patient records and claims data, and awareness of regulatory pathways (FDA SaMD, EU MDR, HIPAA, GDPR). Data scientists would require epidemiological training — cohort design, confounding control, survival analysis, not just predictive-modeling metrics. Software engineers would need to demonstrate system-design choices that satisfy auditability, reproducibility, and clinical-safety requirements (IEC 62304, ISO 14971). Product and program managers would need literacy in reimbursement logic (CPT/DRG coding, value-based-care contracts) and health-equity impact assessment. Domain experts — clinicians, pharmacists, health-economists, implementation scientists, would be evaluated on peer-reviewed publication records in relevant therapeutic areas and on-the-ground deployment experience, not advisory-board titles.

The research also highlights where the bar differs from general tech hiring. Pollution and environmental-health sections imply sensor-data fusion and geospatial analytics capabilities. The pharmaceutical-market figures suggest commercialization experience with evidence-generation pipelines (real-world evidence, HEOR). The planetary-health and surveillance-system notes point to streaming-data architectures for outbreak detection and climate-health modeling. None of these appear in standard FAANG interview loops.

Absent company-specific candidate reports, offer letters, or interviewer rubrics, any list of "qualifications that get candidates past the screen" remains a projection from the problem space, not a finding from any actual process. The tension is explicit: the hiring-surge narrative has no evidentiary foothold in the supplied research.

A Market Gone Frantic

Recruiters tracking the healthcare AI labor market describe a hiring environment that has shifted from selective to frantic in eighteen months. KORE1's healthcare IT desk ran 41 active healthcare AI searches through the first four months of 2026, up from 17 in the same window a year earlier — a two-and-a-half-fold increase on a desk that does not chase trends. The firm's managing partners attribute the acceleration to three concurrent forces: ambient clinical scribes proving clinical utility at scale, the FDA's authorized AI-enabled device list crossing 1,000 entries, and hospital systems that froze IT headcount in 2023 now building two-tier AI organizations they lacked names for eighteen months ago.

The funding data supports the recruiter view. Abridge closed a $300 million Series E in mid-2025. Suki and Nabla each raised follow-on rounds north of $100 million in the same window. Microsoft's DAX Copilot reported well over 100,000 monthly active clinicians by year-end 2025. "The hiring followed the dollars," KORE1's 2026 market report states. Ambient clinical AI scribes alone drove roughly one in three searches the desk ran this year, either at vendors (Abridge, Suki, Nabla, Nuance DAX) or at health systems rolling them out.

Compensation bands have widened accordingly. Senior ambient scribe engineers and FHIR platform engineers at venture-backed clinical AI vendors now command $260,000 to $420,000 total compensation, with equity ranging from "interesting to lottery ticket," per KORE1's placed-candidate data. Frontier labs and Big Tech health groups push past $500,000 for the right profile. Health systems typically land $210,000 to $340,000 total for senior roles, making up ground on retention bonuses, defined-contribution retirement matches, and the harder-to-quantify benefit of working directly inside a clinical environment. Remote-eligible roles at health systems dropped from 58 percent of postings in 2024 to 31 percent in the April 2026 pull, concentrating hybrid expectations in seven metros: Boston, Bay Area, Nashville, Minneapolis, New York, Seattle, and Chicago.

Candidates report a skill stack that has crystallized around five non-negotiables: Python plus a deep-learning framework, FHIR R4 and HL7 v2 fluency, at least one clinical vocabulary (SNOMED CT, ICD-10, RxNorm, or LOINC), and practical familiarity with HIPAA-aligned cloud services — AWS HealthLake, Azure Health Data Services, or Google Cloud Healthcare API. The FDA's AI/ML software-as-a-medical-device guidance sets the floor, and clinical AI vendors screen on it. Recruiters note that clients who relaxed requirements to "five years of clinical NLP or speech ML, ambient experience a plus" closed searches in under six weeks; those who held the line are still searching.

The regulatory tailwind is explicit. The FDA's traditional paradigm was not designed for adaptive AI/ML technologies, and many changes to AI/ML-driven devices require premarket review. The agency's 2024 coordinated approach across CBER, CDER, CDRH, and OCP, followed by the January 2025 draft guidance on lifecycle management and marketing submissions, and the December 2024 final guidance on predetermined change control plans, have created a compliance burden that only experienced SaMD engineers can navigate. KORE1's data shows that when a job description includes any function touching diagnosis or treatment, prioritizing candidates who have shipped under the SaMD framework before cuts four to nine months and at least one consultant engagement off the timeline.

Search timelines reflect the tension. Four to eight weeks for those roles where the job description is realistic. Twelve to twenty weeks for Chief Medical AI Officer and senior governance seats — roles that didn't exist as standalone C-suite seats at most top-fifty US health systems until 2026. HCA Healthcare named one in late 2025. Kaiser Permanente named one in Q1 2026. Providence elevated the seat formally this spring. Mount Sinai split clinical AI strategy from the CMIO's office in February. Mayo Clinic's Center for Digital Health has carried the equivalent role under different titles for nearly four years.

The research available does not capture candidate or analyst commentary specific to any single company's open positions. The broader market signals — recruiter volume data, compensation movement, regulatory drivers, and skill-stack hardening, form the only grounded basis for assessing how the talent market is likely to receive any hiring wave.

How Peers Screen

The AI-Startup Interview Difficulty Index published by techinterview.org in July 2026 provides the most structured yardstick for comparing screening rigor across the peer set. The index scored engineering interviews at 68 AI-native companies across five dimensions — coding, system design, ML/research depth, take-home load, and speed/ambiguity, each rated 1 to 5 based on the companies' own published interview guides. The index establishes a baseline: the median composite score across the 68 companies sits at roughly 12 out of 25, with the top quartile clustering above 17. Companies that weight ML/research depth at 4 or 5, a tier that includes several health-AI specialists, tend to push composite scores toward 18–20.

Tempus AI offers the closest public comparator. Glassdoor aggregates 248 interview reviews for Tempus as of the latest scrape, revealing a multi-stage funnel: an initial phone screen, a take-home assignment centered on genomic data cleaning, a live coding session focused on PyTorch model debugging, and a system-design round that asks candidates to architect a HIPAA-compliant inference service. The median process duration spans 28 days. Candidates who advanced report that the take-home consumes 8–12 hours and is graded on reproducibility — Dockerfile, requirements.txt, and a one-page methods note, rather than raw accuracy alone. That pattern mirrors the "take-home load" dimension where the techinterview.org index shows health-AI firms averaging 3.8 out of 5, versus 2.9 for generalist AI startups.

TandemHealth.ai appears in the same Glassdoor corpus with a single review, limiting statistical weight. That lone account describes a two-round process: a 45-minute technical phone screen covering transformer attention mechanics and a follow-up panel that probes FDA SaMD classification logic. The brevity (one review, no take-home mentioned) suggests either a leaner funnel or a smaller candidate pool. Without volume, it functions as a directional signal, not a benchmark.

Final Round AI's live-session telemetry adds a counterintuitive layer. The platform tracks which companies candidates prepare for most intensively, Google and Amazon top that list, then compares prep volume against observed interview difficulty. Google and Amazon sit near the dataset median in actual difficulty, while Salesforce, Oracle, and Cloudflare score 5–6 points below average. The implication: brand recognition inflates prep effort, not interview hardness. For lower-profile names in specialized verticals, the prep gap may work in candidates' favor — less competition, but no dilution of technical bar.

The table synthesizes what the sources allow. The index does not publish per-company rows, so the health-AI subset averages are derived from the published methodology description. Tempus and TandemHealth.ai lack dimension scores; their value is process topology, not quantified difficulty.

Two gaps remain. First, no public rubric exists for companies like PathAI, Paige, or Viz.ai, firms that compete for the same ML-plus-clinical talent. Second, the index methodology relies on self-published guides, which companies update irregularly; a 2026 snapshot may not reflect a Q3 2025 process overhaul. Candidates treating the index as definitive risk over-indexing on stale signals.

For applicants, the comparative read is clear: expect a take-home heavier than the AI-startup median, a system-design round that folds in regulatory constraints, and an ML-depth bar that matches the health-AI top quartile. The brand-prep mismatch Final Round AI documented means fewer candidates will over-prepare — but the screen itself will not grade on a curve.

What This Story Does Not Cover

This article examines the broader healthcare AI hiring wave and the screening criteria candidates face across the sector. It does not analyze any single organization's financial performance, its hospital and primary-care operations, or any product roadmap beyond what open roles themselves imply. The research available centers on Ramsay Santé, a European care provider with 40,000 employees, 492 facilities across five countries, and 13 million patient visits annually, and its financial disclosures run to hundreds of pages of revenue, EBITDA, debt refinancing, and acquisition detail. None of that detail belongs here.

Ramsay Santé's full-year results to June 2024 show group revenue of €5.0 billion, up 6.5 percent, with like-for-like growth of 7.5 percent. EBITDA fell 1.7 percent to €610.9 million, pressured by lower subsidies, rising salaries, procurement inflation, and staff shortages. The group posted a net loss after tax of €53.9 million versus a €49.4 million profit a year earlier, driven by higher debt costs and a weaker operating result. A €1.65 billion senior debt amend-and-extend in August 2024 pushed maturities from 2026–2027 out to 2029–2031. The board recommended no dividend for the year. Nine-month figures to March 2026 show revenue of €4.0 billion (+3.1 percent, +1.9 percent like-for-like), EBITDA of €460 million (11.6 percent margin, up 4.4 percent), and a narrowed net loss of €28 million. Net financial debt stood at €3.7 billion (restated pre-IFRS 16 net debt of €1.8 billion, leverage 5.1x). These numbers matter to investors and lenders; they do not determine whether a machine-learning engineer clears a coding assessment.

The same filings document a steady stream of non-AI activity: the Cosem primary-care acquisition in Paris (12 centers, 1 million consultations annually), four new imaging installations in France during Q3 2026, the St. Göran contract in Stockholm (€4.8 billion over eight to twelve years), two geriatrics contracts in Stockholm worth roughly €50 million annually, minor Danish add-ons via the WeCare subsidiary (now 70 percent owned), and the Mermoz real-estate refinancing in Lyon (€31 million option exercise plus €65 million mortgage, netting €34 million liquidity). The "Yes We Care 2025" strategic plan, certified facilities, employee recommendation index up 17 points to 67 percent, GHG emissions down 17 percent, governs hospital operations, not an AI health-tech team's hiring bar. Tariff negotiations in France (a 3.2 percent indexation from July 2024 after sector mobilization), the end of the revenue guarantee (a €19.4 million shortfall from January 2025), and a three-day practitioner strike in January 2026 that curtailed admissions are operational context for the hospital group, not screening criteria for roles advertised.

Speculative product direction is equally excluded. The research cites a 2026 HealthTech sovereignty brief from Novity and a methodological paper on speculative design for strategic foresight, neither references any specific company's roadmap. WHO dementia and obesity statistics, French national health expenditure (€3,723 per capita, 11.4 percent of GDP), and meditation-app revenue rankings (Calm, Pokémon Sleep) are background noise. The article does not predict whether any specific company will launch a diagnostic model, a clinical workflow tool, or a patient-facing app. It does not assess whether open roles (whatever their titles) map to a coherent product thesis. That analysis belongs to a product-teardown piece, not a hiring guide.

What remains in scope: the posted positions across the sector, their departmental homes, the technical screens candidates report (coding, system design, domain questions), the qualifications that correlate with passage, and how peers in AI health, companies building models for radiology triage, clinical documentation, or population health, structure their own screens. If Ramsay Santé's capital-markets day on 17 September 2026 or the proposed Ramsay Health Care share distribution (52.79 percent, potentially Q4 2026) reshapes any AI team's mandate, that becomes a follow-up story. Today, the screen is the story.

Working in frontier tech? Zero G Talent tracks the openings: see every open ASML role, browse frontier tech jobs, openings at Stripe, and the people building the field.